Thursday, September 30, 2004
The FDA report on counterfeit drugs has only been out for seven months and already at least one group has stepped forward to show that a “track and trace” method of tracking drugs is feasible.
On Sept. 28, a group managed by Accenture released its first report on utilizing EPC and RFID technologies across the pharmaceutical supply chain. The group was first formed back in February, days after the FDA report was released, and includes pharmaceutical manufacturers, distributors and retailers.
Findings based on shipping, tracking and tracing nearly 13,500 packages of pharmaceuticals over an eight week period, showed that EPC/RFID can help satisfy regulatory and retailer requirements, increase product security and consumer safety, enhance order accuracy and labor productivity, and increase the efficiency and speed of recalls and returns, according to Accenture. These tests, however, applied to the supply chain only and did not involve consumer-level testing.